Procedure
NeoPUTTY MTA
NeoPUTTY MTA is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Not yet recruiting1
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
not_yet_recruiting133%
active_not_recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Outcomes of Partial Pulpotomy VS Ful Pulpotomy Using MTA in Primary Teeth
NCT07717294
not_yet_recruitingnot_applicable
Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars
NCT07437794
unknownnot_applicable
Indirect Pulp Treatment in Primary Teeth
NCT04763057
Clinical Trials (3)
Showing 3 of 3 trials
NCT07717294Not Applicable
Outcomes of Partial Pulpotomy VS Ful Pulpotomy Using MTA in Primary Teeth
NCT07437794Not Applicable
Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars
NCT04763057Not Applicable
Indirect Pulp Treatment in Primary Teeth
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3